ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts

March 5, 1993

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

Funding Opportunities

December 6, 2002

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003